Caprock Group, Inc. Exact Sciences Corp Transaction History

Caprock Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $139,588 - $211,676	2,227 New	2,227 $209,000
Q3 2021 Oct 07, 2021	SELL	$90.24 - $124.05 $238,053 - $327,243	-2,638 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $21,541 - $32,032	230 Added 9.55%	2,638 $328,000
Q1 2021 Apr 29, 2021	BUY	$116.57 - $155.01 $8,159 - $10,850	70 Added 2.99%	2,408 $317,000
Q4 2020 Jan 29, 2021	BUY	$99.61 - $142.12 $5,179 - $7,390	52 Added 2.27%	2,338 $310,000
Q3 2020 Oct 29, 2020	SELL	$72.92 - $102.01 $875 - $1,224	-12 Reduced 0.52%	2,286 $233,000
Q2 2020 Aug 05, 2020	BUY	$55.75 - $92.75 $128,113 - $213,139	2,298 New	2,298 $200,000
Q2 2018 Jul 23, 2018	SELL	$37.84 - $69.96 $240,662 - $444,945	-6,360 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$39.82 - $57.53 $253,255 - $365,890	6,360 New	6,360 $256,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.